BR0212409A - Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico - Google Patents

Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico

Info

Publication number
BR0212409A
BR0212409A BR0212409-2A BR0212409A BR0212409A BR 0212409 A BR0212409 A BR 0212409A BR 0212409 A BR0212409 A BR 0212409A BR 0212409 A BR0212409 A BR 0212409A
Authority
BR
Brazil
Prior art keywords
animal
treating
steroid compound
human person
androgenic effect
Prior art date
Application number
BR0212409-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Jaap Van Der Louw
Dirk Leysen
Marcel Evert De Gooijer
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0212409(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0212409A publication Critical patent/BR0212409A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0062Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0212409-2A 2001-09-12 2002-09-06 Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico BR0212409A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (1)

Publication Number Publication Date
BR0212409A true BR0212409A (pt) 2004-08-03

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212409-2A BR0212409A (pt) 2001-09-12 2002-09-06 Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico

Country Status (28)

Country Link
US (1) US7169769B2 (cg-RX-API-DMAC7.html)
EP (1) EP1427748B1 (cg-RX-API-DMAC7.html)
JP (1) JP4471653B2 (cg-RX-API-DMAC7.html)
KR (1) KR100940054B1 (cg-RX-API-DMAC7.html)
CN (1) CN1257913C (cg-RX-API-DMAC7.html)
AR (1) AR036462A1 (cg-RX-API-DMAC7.html)
AT (1) ATE395352T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002339536B2 (cg-RX-API-DMAC7.html)
BR (1) BR0212409A (cg-RX-API-DMAC7.html)
CA (1) CA2505575C (cg-RX-API-DMAC7.html)
CY (1) CY1108152T1 (cg-RX-API-DMAC7.html)
DE (1) DE60226623D1 (cg-RX-API-DMAC7.html)
DK (1) DK1427748T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP045012A (cg-RX-API-DMAC7.html)
ES (1) ES2305306T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20040193A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0402139A3 (cg-RX-API-DMAC7.html)
IL (2) IL160451A0 (cg-RX-API-DMAC7.html)
IS (1) IS2555B (cg-RX-API-DMAC7.html)
MX (1) MXPA04002418A (cg-RX-API-DMAC7.html)
NO (1) NO326624B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ531487A (cg-RX-API-DMAC7.html)
PL (1) PL207493B1 (cg-RX-API-DMAC7.html)
PT (1) PT1427748E (cg-RX-API-DMAC7.html)
RU (1) RU2294332C2 (cg-RX-API-DMAC7.html)
TW (1) TWI221154B (cg-RX-API-DMAC7.html)
WO (1) WO2003022864A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200401992B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
CA2359218A1 (en) 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
RU2004110934A (ru) 2005-08-20
CA2505575C (en) 2010-01-26
PT1427748E (pt) 2008-08-27
KR20040039346A (ko) 2004-05-10
HK1063637A1 (en) 2005-01-07
CN1257913C (zh) 2006-05-31
TWI221154B (en) 2004-09-21
RU2294332C2 (ru) 2007-02-27
JP4471653B2 (ja) 2010-06-02
MXPA04002418A (es) 2004-07-30
US20040259849A1 (en) 2004-12-23
ZA200401992B (en) 2005-04-21
HUP0402139A2 (hu) 2005-02-28
DK1427748T3 (da) 2008-09-08
EP1427748A1 (en) 2004-06-16
HUP0402139A3 (en) 2012-12-28
IL160451A0 (en) 2004-07-25
NO20041010L (no) 2004-03-10
IL160451A (en) 2009-11-18
AU2002339536B2 (en) 2008-04-24
CN1553917A (zh) 2004-12-08
HRP20040193A2 (en) 2004-08-31
ATE395352T1 (de) 2008-05-15
PL207493B1 (pl) 2010-12-31
EP1427748B1 (en) 2008-05-14
JP2005505566A (ja) 2005-02-24
US7169769B2 (en) 2007-01-30
CA2505575A1 (en) 2003-03-20
NO326624B1 (no) 2009-01-19
KR100940054B1 (ko) 2010-02-04
NZ531487A (en) 2005-08-26
ES2305306T3 (es) 2008-11-01
IS2555B (is) 2009-10-15
DE60226623D1 (de) 2008-06-26
AR036462A1 (es) 2004-09-08
ECSP045012A (es) 2004-09-27
WO2003022864A1 (en) 2003-03-20
IS7165A (is) 2004-02-26
PL368727A1 (en) 2005-04-04
CY1108152T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
BR0317891A (pt) Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
SE8603046D0 (sv) Substituted androsta-1,4-diene-3,17-diones and process for their preparation
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
BR0104654A (pt) Artigo absorvente
EP1377245A4 (en) IMMUNOSTIMULATING COATING FOR SURGICAL DEVICES
BR0208936A (pt) composição aquosa para tornar um substrato hidrofóbico
BR0312092A (pt) Uso de derivados de tio-oxindol no tratamento de distúrbios da pele
MXPA03011626A (es) Derivados de quinazolina que promueven la liberacion de hormona paratiroides.
HUP0104339A2 (hu) Eljárás porckárosodások kezelésére
BR0212409A (pt) Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico
BRPI0501718A (pt) método de tratamento de fibra de cabelo sem etapa de fixação do cabelo e uso do método
BR0207413A (pt) Composição de condicionamento de tecidos, e, método para o tratamento de tecidos
ES2171943T3 (es) Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina.
HUP0301123A3 (en) Use of exemestane for treatment of hormone-dependent breast cancer
CA2001264A1 (en) 3.beta.,17.beta.-hydroxy-substituted steroids and related steroidal compounds
BR0214564A (pt) Processos de tratamento de câncer utilizando um inibidor da fpt e agentes antineoplásicos
DE3062238D1 (en) Method for enhancing growth rate and feed efficiency of ruminants
IL142776A0 (en) Use of phosphonoformic acid derivatives for treating infections
BR0212408A (pt) Composição de condicionamento de tecido, e, método para o tratamento de tecidos.
FI932446A0 (fi) 2b,19-metylaminobrosteroider som aromatasinhibitorer
PT934745E (pt) Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias
YU63004A (sh) Postupak za izradu 7alfa-metilsteroida
PE20020752A1 (es) Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena
BR9908605A (pt) Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.